Parallax Volatility Advisers, L.P. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,107
+19.1%
105,107
-1.6%
0.00%
Q4 2022$11,001
-83.3%
106,807
-75.2%
0.00%
Q3 2022$66,000
+3.1%
431,407
+490.7%
0.00%
Q2 2022$64,000
-39.0%
73,037
-13.9%
0.00%
Q1 2022$105,000
-43.2%
84,837
-10.6%
0.00%
Q4 2021$185,000
+51.6%
94,941
+113.7%
0.00%
Q3 2021$122,000
-12.9%
44,4370.0%0.00%
Q2 2021$140,000
+47.4%
44,4370.0%0.00%
Q1 2021$95,000
+10.5%
44,4370.0%0.00%
Q4 2020$86,000
+177.4%
44,4370.0%0.00%
Q3 2020$31,000
+34.8%
44,4370.0%0.00%
Q2 2020$23,000
+15.0%
44,4370.0%0.00%
Q1 2020$20,000
-35.5%
44,4370.0%0.00%
Q4 2019$31,000
-35.4%
44,4370.0%0.00%
Q3 2019$48,000
+50.0%
44,4370.0%0.00%
Q2 2019$32,000
-43.9%
44,4370.0%0.00%
Q1 2019$57,000
-14.9%
44,4370.0%0.00%
Q4 2018$67,000
+4.7%
44,4370.0%0.00%
Q3 2018$64,000
+4.9%
44,4370.0%0.00%
Q2 2018$61,000
+48.8%
44,4370.0%0.00%
Q1 2018$41,000
-16.3%
44,4370.0%0.00%
Q4 2017$49,000
-88.9%
44,437
-83.9%
0.00%
-100.0%
Q3 2017$441,000
-14.5%
275,8480.0%0.00%0.0%
Q2 2017$516,000
-4.6%
275,8480.0%0.00%0.0%
Q1 2017$541,000
-48.8%
275,848
-2.7%
0.00%
-50.0%
Q4 2016$1,057,000
-14.4%
283,450
-2.9%
0.00%0.0%
Q3 2016$1,235,000
+7.7%
292,000
-0.7%
0.00%0.0%
Q2 2016$1,147,000294,1000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders